| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President &CEO | President And CEO
1 company
Usman Nassim is a Director at GYRE THERAPEUTICS, INC.. Recent SEC Form 4 filings include 6 buys and 6 sells.
Estimated insider holdings value: $10K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28, 2024 | GYRE Gyre Therapeutics, Inc. | Director | Sale+OE | 3,452 | $12.00 | $41,437.81 | -67.8% | +7.3% | -37.8% | |
| May 1, 2024 | GYRE Gyre Therapeutics, Inc. | Director | Sale+OE | 20,000 | $14.13 | $282,577.00 | -66.4% | +2.7% | -32.6% | |
| Apr 1, 2024 | GYRE Gyre Therapeutics, Inc. | Director | Sale+OE | 20,000 | $16.15 | $323,000.00 | -92.4% | -24.0% | -59.6% | |
| Mar 15, 2024 | GYRE Gyre Therapeutics, Inc. | Director | Sale+OE | 20,000 | $17.26 | $345,200.00 | -92.4% | -34.1% | -27.7% | |
| Aug 9, 2022 | GYRE Gyre Therapeutics, Inc. | President &CEO | Buy | 3,250 | $0.47 | $1,527.50 | +15.3% | +13.8% | +14.8% | |
| Feb 9, 2022 | GYRE Gyre Therapeutics, Inc. | President &CEO | Buy | 3,250 | $0.46 | $1,495.00 | +18.0% | -33.9% | +192.0% | |
| Aug 9, 2021 | GYRE Gyre Therapeutics, Inc. | President &CEO | Buy | 867 | $3.62 | $3,138.54 | +5.0% | -26.5% | -57.0% | |
| Feb 9, 2021 | GYRE Gyre Therapeutics, Inc. | President &CEO | Buy | 582 | $4.81 | $2,799.42 | +5.0% | - | - | |
| Aug 10, 2020 | GYRE Gyre Therapeutics, Inc. | President &CEO | Buy | 582 | $4.81 | $2,799.42 | +5.3% | - | - | |
| Mar 13, 2020 | GYRE Gyre Therapeutics, Inc. | President &CEO | Buy | 4,000 | $3.91 | $15,647.20 | +57.1% | - | - |